🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
Platelets correspond to one of the most widely used blood components in tra...
Status
Unknown
Location
Hospital Britanico Buenos Aires
Start Date
2021-02-03
Trial ID
NCT04754841
Treatments Being Tested
A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopres...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
1999-07-23
Trial ID
NCT00038012
Treatments Being Tested
This study will try to determine what causes toxic side effects of stem cel...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2008-02-29
Trial ID
NCT00631787
A Phase III study of PLX-PAD for CLI patients with minor tissue loss who ar...
Status
No Longer Available
Location
OBL-NJ Endovascular & Amputation Prevention, LLC,1429 Broad St., Clifton, NJ
Start Date
TBD
Trial ID
NCT03886506
Treatments Being Tested
Erdheim-Chester Diseases (ECD) is a very rare non-Langerhans cell histiocyt...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-11-01
Trial ID
NCT02281760
Treatments Being Tested
A randomized, parallel group, active comparator-controlled trial to evaluat...
Status
Completed
Location
University of Alabama
Start Date
2021-10-27
Trial ID
NCT04709705
Treatments Being Tested
The purpose of this research study is to evaluate the safety and effect of ...
Status
Active Not Recruiting
Location
Mayo Clinic in Florida
Start Date
2023-11-03
Trial ID
NCT06001853
Treatments Being Tested
The investigators are studying whether MSM plus standard of care naproxen i...
Status
Completed
Location
Mike O'Callaghan Federal Medical Center
Start Date
2015-02
Trial ID
NCT02268305
Treatments Being Tested
This phase II trial studies how well de-escalating the drugs dabrafenib and...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-11-07
Trial ID
NCT07110246